Clopidogrel Hydrobromide

CHEMBL6068343 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

402.7 g/mol

LogP

—

Phase

4

A hydrobromide salt form of clopidogrel that works by preventing platelets in the blood from clumping together to form clots. It is used to reduce the risk of serious cardiovascular events.

분자량

402.7000 g/mol

TPSA

57.80 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

Br.COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1

InChI

InChI=1S/C16H16ClNO2S.BrH/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;/h2-5,7,9,15H,6,8,10H2,1H3;1H/t15-;/m0./s1

Molecular Formula

C16H17BrClNO2S

HBD / HBA

1 / 4

회전 가능 결합

4

무거운 원자

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

A hydrobromide salt form of clopidogrel that works by preventing platelets in the blood from clumping together to form clots. It is used to reduce the risk of serious cardiovascular events.

Yes, Clopidogrel Hydrobromide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6068343. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 11304210. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Clopidogrel Hydrobromide PillFYI에서

구조

핵심 데이터

분자식: C16H17BrClNO2S

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.